Medtronic, DePuy Synthes in spine: 5 key comparisons

Laura Dyrda -   Print  |

Medtronic and Johnson & Johnson's DePuy Synthes lead the spine market and continue to make interesting moves to expand their presence in the field.

Here are five key points of comparison:

1. Financials
Medtronic: Restorative Therapies Group (including spine) has $8.2 billion in revenue
DePuy Synthes: $10 billion in annual sales

2. Quarterly spine revenue
Medtronic reported spine revenue dropped 31 percent year over year to $480 million in the fourth quarter of the 2020 fiscal year, the most recent quarter reported. BMP sales were down as well, more than 30 percent.

Johnson & Johnson Orthopaedics reported $2 billion in worldwide revenue for the first quarter of 2020, a 7.5 percent year-over-year drop. Quarterly spine, sports and other sales were down 10.7 percent to $703 million.

3. Market share
Medtronic: 29 percent
DePuy Synthes: 16 percent

*According to The Spine Market Group.

4. Leadership
Brett Wall is the executive vice president and president of Medtronic's Restorative Therapies Group, which includes brain therapies, pain therapies, specialty therapies and spine. He previously served as the senior vice president of the group's brain therapies division and served as president of Covidien's neurovascular and international business before Medtronic acquired the company.

Ashley McEvoy is the executive vice president and worldwide chairman of medical devices at Johnson & Johnson. She leads the company's surgery, orthopedics, interventional solutions and eye health businesses. Ms. McEvoy has previous experience in leadership roles with Johnson & Johnson, and co-led the integration of Pfizer Consumer Healthcare into NcNeil, which is the company's largest integration.

5. Big moves
Medtronic acquired Titan Spine in 2019 for an undisclosed amount. The company contributed $15 million to Medtronic's fourth quarter revenue. Medtronic acquired the Mazor robotic technology for spine surgery in December 2018 and has since worked with the company to develop the Mazor X Stealth Edition.

On Sept. 25, Johnson & Johnson Medical Device Companies' DePuy Synthes launched the Conduit Interbody Platform with EIT cellular titanium technology, which includes 3D printed titanium implants for spinal fusion.

More articles on devices:
Setting spine practices up for success post-pandemic: 5 industry insights
UAMS begins data gathering initiative with spine patients
3 spine surgeons on the move in June

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers